稳健医疗
(300888)
| 流通市值：56.84亿 | | | 总市值：184.14亿 |
| 流通股本：1.82亿 | | | 总股本：5.88亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,909,017,281.07 | 8,185,022,057.2 | 6,010,442,517 | 4,266,838,038.66 |
| 营业收入 | 1,909,017,281.07 | 8,185,022,057.2 | 6,010,442,517 | 4,266,838,038.66 |
| 二、营业总成本 | 1,707,213,229.42 | 7,285,343,794.63 | 5,112,656,537.02 | 3,500,655,804.36 |
| 营业成本 | 999,874,135.44 | 4,174,597,287.74 | 2,994,955,389.26 | 2,071,428,206.72 |
| 税金及附加 | 16,313,320.76 | 66,413,470.87 | 50,010,713.43 | 37,346,208.61 |
| 销售费用 | 477,837,652.89 | 2,090,492,506.1 | 1,445,506,563.06 | 960,442,911.44 |
| 管理费用 | 151,789,137.17 | 693,647,621.42 | 430,384,084.74 | 289,596,702.14 |
| 研发费用 | 75,999,859.76 | 322,051,868.43 | 268,896,680.42 | 194,636,202.14 |
| 财务费用 | -14,600,876.6 | -61,858,959.93 | -77,096,893.89 | -52,794,426.69 |
| 其中:利息费用 | 11,255,576 | 63,441,562.69 | 48,395,021.97 | 32,891,514.25 |
| 其中:利息收入 | 23,584,993.14 | 133,913,862.72 | 108,787,535.6 | 69,863,134.66 |
| 加:公允价值变动收益 | 14,430,436.62 | 46,678,103.27 | 59,575,027.27 | 59,639,836.03 |
| 加:投资收益 | 14,686,022.3 | 127,342,880.98 | 75,841,901.89 | 39,412,441.13 |
| 资产处置收益 | 797,543.99 | 32,201,950.01 | 1,601,841,961.82 | 5,324,751.1 |
| 资产减值损失(新) | -17,745,343.35 | -393,762,054.87 | -147,432,281.86 | -100,794,883.37 |
| 信用减值损失(新) | -5,053,372.8 | 4,725,509.3 | 201,628.94 | 2,831,973.61 |
| 其他收益 | 17,354,528.51 | 101,105,274.61 | 69,648,999.28 | 46,680,694.51 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 226,273,866.92 | 817,969,925.87 | 2,557,463,217.32 | 819,277,047.31 |
| 加:营业外收入 | 2,253,121.57 | 16,618,496.48 | 8,777,607.21 | 6,702,598.77 |
| 减:营业外支出 | 4,766,165.47 | 84,742,148.34 | 10,499,012.19 | 4,906,948.03 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 223,760,823.02 | 749,846,274.01 | 2,555,741,812.34 | 821,072,698.05 |
| 减:所得税费用 | 30,247,700.49 | 121,301,087.57 | 369,809,886.4 | 114,886,459.15 |
| 六、净利润 | 193,513,122.53 | 628,545,186.44 | 2,185,931,925.94 | 706,186,238.9 |
| 持续经营净利润 | 193,513,122.53 | 628,545,186.44 | 2,185,931,925.94 | 706,186,238.9 |
| 归属于母公司股东的净利润 | 182,424,811.95 | 580,403,232.37 | 2,147,773,293.68 | 681,617,022.69 |
| 少数股东损益 | 11,088,310.58 | 48,141,954.07 | 38,158,632.26 | 24,569,216.21 |
| (一)基本每股收益 | 0.31 | 0.98 | 3.65 | 1.16 |
| (二)稀释每股收益 | 0.31 | 0.98 | 3.65 | 1.16 |
| 八、其他综合收益 | 1,028,878.34 | 2,623,741.12 | 1,918,869.33 | 2,650,491.58 |
| 归属于母公司股东的其他综合收益 | 599,560.21 | 1,432,591.3 | 1,168,773.22 | 1,563,872.28 |
| 九、综合收益总额 | 194,542,000.87 | 631,168,927.56 | 2,187,850,795.27 | 708,836,730.48 |
| 归属于母公司股东的综合收益总额 | 183,024,372.16 | 581,835,823.67 | 2,148,942,066.9 | 683,180,894.97 |
| 归属于少数股东的综合收益总额 | 11,517,628.71 | 49,333,103.89 | 38,908,728.37 | 25,655,835.51 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-24 | 2023-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |